OGEN
Price
$4.28
Change
+$0.75 (+21.25%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
3.06M
REVB
Price
$0.86
Change
+$0.05 (+6.17%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
3.96M
Interact to see
Advertisement

OGEN vs REVB

Header iconOGEN vs REVB Comparison
Open Charts OGEN vs REVBBanner chart's image
Oragenics
Price$4.28
Change+$0.75 (+21.25%)
Volume$200
Capitalization3.06M
Revelation Biosciences
Price$0.86
Change+$0.05 (+6.17%)
Volume$21.31K
Capitalization3.96M
OGEN vs REVB Comparison Chart
Loading...
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OGEN vs. REVB commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGEN is a Hold and REVB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (OGEN: $3.53 vs. REVB: $0.81)
Brand notoriety: OGEN and REVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OGEN: 78% vs. REVB: 87%
Market capitalization -- OGEN: $3.06M vs. REVB: $3.96M
OGEN [@Biotechnology] is valued at $3.06M. REVB’s [@Biotechnology] market capitalization is $3.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGEN’s FA Score shows that 0 FA rating(s) are green whileREVB’s FA Score has 2 green FA rating(s).

  • OGEN’s FA Score: 0 green, 5 red.
  • REVB’s FA Score: 2 green, 3 red.
According to our system of comparison, REVB is a better buy in the long-term than OGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGEN’s TA Score shows that 4 TA indicator(s) are bullish while REVB’s TA Score has 4 bullish TA indicator(s).

  • OGEN’s TA Score: 4 bullish, 3 bearish.
  • REVB’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, OGEN is a better buy in the short-term than REVB.

Price Growth

OGEN (@Biotechnology) experienced а +2445.06% price change this week, while REVB (@Biotechnology) price change was -7.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.92%. For the same industry, the average monthly price growth was +17.56%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

OGEN is expected to report earnings on Mar 14, 2025.

REVB is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+11.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REVB($3.96M) has a higher market cap than OGEN($3.06M). OGEN YTD gains are higher at: -68.138 vs. REVB (-88.951). REVB has higher annual earnings (EBITDA): -7.95M vs. OGEN (-10.11M). REVB has less debt than OGEN: REVB (0) vs OGEN (2.55M). OGEN (0) and REVB (0) have equivalent revenues.
OGENREVBOGEN / REVB
Capitalization3.06M3.96M77%
EBITDA-10.11M-7.95M127%
Gain YTD-68.138-88.95177%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A6.5M-
Total Debt2.55M0-
FUNDAMENTALS RATINGS
OGEN: Fundamental Ratings
OGEN
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OGENREVB
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 25 days ago
81%
Bullish Trend 16 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DHX2.400.08
+3.45%
DHI Group
GLNG41.820.60
+1.46%
Golar Lng Ltd
CSTL17.030.01
+0.06%
Castle Biosciences
CLEU1.03N/A
N/A
China Liberal Education Holdings Limited
PODD317.16-2.05
-0.64%
Insulet Corp

OGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGEN has been loosely correlated with ATHA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if OGEN jumps, then ATHA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGEN
1D Price
Change %
OGEN100%
-4.59%
ATHA - OGEN
44%
Loosely correlated
+2.61%
REVB - OGEN
35%
Loosely correlated
-7.85%
SRPT - OGEN
30%
Poorly correlated
-0.83%
LYRA - OGEN
28%
Poorly correlated
+9.07%
CHRS - OGEN
27%
Poorly correlated
+0.48%
More

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
-7.85%
GNPX - REVB
48%
Loosely correlated
-2.19%
TCRT - REVB
46%
Loosely correlated
+0.79%
OGEN - REVB
35%
Loosely correlated
-4.59%
IMUX - REVB
33%
Loosely correlated
-1.38%
TOVX - REVB
31%
Poorly correlated
+2.84%
More